1. Home
  2. AOMR vs STXS Comparison

AOMR vs STXS Comparison

Compare AOMR & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AOMR

Angel Oak Mortgage REIT Inc.

N/A

Current Price

$8.49

Market Cap

218.7M

Sector

Real Estate

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$2.09

Market Cap

201.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AOMR
STXS
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.7M
201.6M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
AOMR
STXS
Price
$8.49
$2.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$11.31
$4.00
AVG Volume (30 Days)
91.4K
405.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
14.88%
N/A
EPS Growth
53.85
N/A
EPS
1.80
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$24.21
Revenue Next Year
$0.83
$29.83
P/E Ratio
$4.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.36
$1.54
52 Week High
$10.21
$3.59

Technical Indicators

Market Signals
Indicator
AOMR
STXS
Relative Strength Index (RSI) 40.50 43.50
Support Level $8.18 $2.06
Resistance Level $8.91 $2.49
Average True Range (ATR) 0.23 0.12
MACD -0.01 0.01
Stochastic Oscillator 31.00 28.77

Price Performance

Historical Comparison
AOMR
STXS

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: